Skip to main content
SpringerLink
Log in

Breast Carcinoma

  • Chapter
Prognostic Factors in Cancer

Abstract

There has been a proliferation of prognostic factors in breast cancer. Currently there are at least 76 putative breast cancer prognostic factors reported in humans. In this chapter the literature for 37 factors is reviewed. The factors that are supported in the literature are not necessarily the final prognostic factors for breast cancer. They deserve further study in an integrative model. The prognostic factors are presented in three tables, each representing a level of analysis, i.e., epidemiologic, anatomic-cellular, and molecular-genetic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ansell D, Whitman S, Lipton R, Cooper R (1993) Race, income, and survival from breast cancer at two public hospitals. Cancer 72: 2974–2978

    Article  PubMed  CAS  Google Scholar 

  2. Barraclough J, Pinder P, Cruddas M, Osmond C, Taylor I, Perry M (1992) Life events and breast cancer prognosis. BMJ 304: 1078–1081

    Article  PubMed  CAS  Google Scholar 

  3. Bastarrachea J, Hortobagyi GN, Smith TL, Kau SC, Buzdar AU (1993) Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med 119: 18–25

    Google Scholar 

  4. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (eds) (1992) Manual for staging of cancer, 4th edn. Lippincott, Philadelphia

    Google Scholar 

  5. Berger U, McClelland RA, Wilson P, Greene GL, Haussler MR, Oike JW et al (1991) Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25–dihydroxyvitamin D3 receptor in breast cancer and the relationship to prognosis. Cancer Res 51: 239–244

    PubMed  CAS  Google Scholar 

  6. Bianchi S, Paglierani M, Zampi G, Cardona G, Cataliotti L, Bonardi R et al (1993) Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients. Cancer 72: 120–125

    Article  PubMed  CAS  Google Scholar 

  7. Bloom H, Richardson W (1957) Histological grading and prognosis in breast cancer. Br J Cancer 9: 359–377

    Article  Google Scholar 

  8. Burke HB, Henson DE (1993) Criteria for prognostic factors and for an enhanced prognostic system. Cancer 72: 3131–3135

    Article  PubMed  CAS  Google Scholar 

  9. Carter CL, Allen C, Henson DE (1988) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181–187

    Article  Google Scholar 

  10. Ciocca DR, Clark GM, Tandon AK, Fuqua SAW, Welch WJ, McGuire WL (1993) Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implica¬tions. J Natl Cancer Inst 85: 570–574

    Article  PubMed  CAS  Google Scholar 

  11. Ciocca DR, Luque EH (1991) Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer. Breast Cancer Res 20: 33–42

    Article  CAS  Google Scholar 

  12. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SAW (1993) Biological and clinical implications of heat shock protein 27 000 (Hsp27): a review. J Natl Cancer Inst 85: 1558–1570

    Article  PubMed  CAS  Google Scholar 

  13. Clayton F, Hopkins CL (1993) Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer 67: 11780–11790

    Google Scholar 

  14. Coates A, Gebski V, Signorini D, Murray P, McNeil D, Byrne M et al (1992) Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. J Clin Oncol 10: 1833–1838

    PubMed  CAS  Google Scholar 

  15. Davidoff AM, Herndon JE, Glover NS, Kerns BM, Pence JC, Inglehart JD, Marks JR (1991) Relation between p53 overexpression and established prognostic factors in breast cancer. Surgery 110: 259–264

    PubMed  CAS  Google Scholar 

  16. Fisher B, Redmond C, Fisher ER, Caplan R (1988) Relative worth of estrogen and progesterone receptors and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients. J Clin Oncol 6: 1076–1087

    PubMed  CAS  Google Scholar 

  17. Foekens JA, van Putten WJ, Portengen H, de Koning H, Thirion B, Alexieva-Figusch J, Klijn JM (1993) Prediction of relapse and survival in breast cancer patients by pS2 protein status. J Clin Oncol 11: 899–908

    CAS  Google Scholar 

  18. Game JP, Aspegren K, Linell F, Rank F, Ranstam J (1994) Primary prognostic factors in invasive breast carcinoma with special reference to ductal carcinoma and histologic malignancy grade. Cancer 73: 1438–1448

    Article  Google Scholar 

  19. Gaspirini G, Weidner N, Bevilacqua P, Maluta S, Palma PD, Caffo O et al (1994) Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic invasion are rel¬evant prognostic markers in node-negative breast carcinoma. J Clin Oncl 12: 454–466

    Google Scholar 

  20. Gilchrist KW, Gray R, Fowble B, Tormey DC, Taylor SG (1993) Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow- up study of 728 eastern cooperative oncology group patients. J Clin Oncol 11: 1929–1935

    PubMed  CAS  Google Scholar 

  21. Gilchrist KW, Kalish L, Gould VE, Hirschl S, Imbriglia JE, Levy WM et al (1985) Interobserver reproducibility of histopathology features in stage II breast cancer: an ECOG study. Breast Cancer Res Treat 5: 3 - 10

    Article  PubMed  CAS  Google Scholar 

  22. Gion M, Mione R, Pappagallo GL, Gatti C, Nascimben O, Brandes A et al (1992) Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic factor. Eur J Cancer 29A: 66 - 69

    Article  Google Scholar 

  23. Going J J, Anderson TJ, Wyllie AH (1992) Ras p21 in breast tissue: association with pathology and cellular localization. Br J Cancer 65: 45–50

    Article  PubMed  CAS  Google Scholar 

  24. Gullick WJ (1991) Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 47: 87–98

    PubMed  CAS  Google Scholar 

  25. Hahnel R (1983) Oestrogen receptors and breast carcinoma. Med J Aust 1: 350–351

    PubMed  CAS  Google Scholar 

  26. Hennessy C, Henry JA, May FEB, Westley BR, Angus B, Lennard TW (1991) Expression of the antimetastatic gene nm23 in human breast cancer: association with good prognosis. J Natl Cancer Inst 83: 281–285

    Article  PubMed  CAS  Google Scholar 

  27. Henson DE, Ries L, Freedman LS, Carriaga M (1991) Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. Cancer 68: 2142–2149

    Article  PubMed  CAS  Google Scholar 

  28. Hermanek P, Sobin LH (eds) (1992) UICC TNM classification of malignant tumours, 4th edn, 2nd revision. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  29. Ip C (1993) Controversial issues of dietary fat and experimental mammary carcinogenesis. Prev Med 22: 728–737

    Article  PubMed  CAS  Google Scholar 

  30. Joensuu H, Toikkanen S (1992) Identification of subgroups with favorable prognosis in breast cancer. Acta Oncol 31: 293–301

    Article  PubMed  CAS  Google Scholar 

  31. Kamby C (1990) The pattern of metastases in human breast cancer: methodologic aspects and influence of prognostic factors. Cancer Res Treat 17: 37–61

    CAS  Google Scholar 

  32. Kandalaft PL, Chang KL, Ahn CW, Traweek ST, Mehta P, Battifora H (1993) Prognostic significance of immunohistochemical analysis of Cathepsin D in low-stage breast cancer. Cancer 71: 2756–2763

    Article  PubMed  CAS  Google Scholar 

  33. Komitowski D, Janson C (1990) Quantitative features of chromatin structure in the prognosis of breast cancer. Cancer 65: 2725–2730

    Google Scholar 

  34. Lipton A, Santen RJ, Santner SJ, Harvey HA, Sanders SI, Matthews MA (1992) Prognostic value of breast cancer aromatase. Cancer 70: 1951–1955

    Article  PubMed  CAS  Google Scholar 

  35. Mansour O, Motawi T, Khaled H, el-Ahmady O (1993) Clinical value of thymidine kinase and tissue polypeptide specific antigen in breast cancer. Dis Markers 11: 171–177

    PubMed  CAS  Google Scholar 

  36. McGuire WL, Clark GM (1992) Prognostic factors and treatment decisions in axillary-node- negative breast cancer. N Engl J Med 326: 1756–1761

    Article  PubMed  CAS  Google Scholar 

  37. McGuire WL, Clark GM, Dressier LG, Owens MA (1986) Role of steroid hormone receptors as prognostic factors in primary breast cancer. NCI Monogr 1: 1–23

    Google Scholar 

  38. McGuire WL, Jackson JG, Figueroa JA, Shimasaki S, Powell DR, Yee D (1992) Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J Natl Cancer Inst 84: 1336–1341

    Article  PubMed  CAS  Google Scholar 

  39. Meyer JS, Koehm SL, Hughes JM, Higa E, Wittliff JL, Lagos JA, Manes JL (1993) Bromo- deoxyuridine labeling for S-phase measurement in breast carcinoma. Cancer 71: 3531–3540

    Article  PubMed  CAS  Google Scholar 

  40. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86: 356–361

    Article  PubMed  CAS  Google Scholar 

  41. O’Neill KL, Hoper M, Odling-Smee GW (1992) Can thymidine kinase levels in breast tumors predict disease recurrence? J Natl Cancer Inst 84: 1825–1828

    Article  PubMed  Google Scholar 

  42. O’Sullivan C, Lewis CE, Harris AL, McGee JO (1993) Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet 342: 148–149

    Article  PubMed  Google Scholar 

  43. Perren TJ (1991) c-erbB-2 oncogene as a prognostic marker in breast cancer. Br J Cancer 63: 328–332

    Google Scholar 

  44. Pertschuk LP, Feldman JG, Kim DS, Nayeri K, Eisenberg KB, Carter AC et al (1993) Steroid hormone receptor immunochemistry and amplification of c-myc protooncogene. Cancer 71: 162 - 171

    Article  PubMed  CAS  Google Scholar 

  45. Pollak M, Costantino J, Polychronakos C, Blauer S, Guyda H, Redmond C et al (1990) Effects of tamoxifen on serum insulin-like growth factor I levels in stage I breast cancer patients. J Natl Cancer Inst 82: 1693–1697

    Article  PubMed  CAS  Google Scholar 

  46. Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua AW, Hilsenbeck SH et al (1994) Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer. J Clin Oncol 12: 467–474

    PubMed  CAS  Google Scholar 

  47. Ries LA, Henson DE, Harras A (1994) Survival from breast cancer according to tumor size and nodal status. Semin Surg Oncol 3: 35–53

    Google Scholar 

  48. Rio MC, Chambon P (1990) The pS2 gene, mRNA and protein: a potential marker for human breast cancer. Cancer Cells 2: 269–274

    PubMed  CAS  Google Scholar 

  49. Rochefordiere AD, Asselain B, Campana F, Scholl SM, Fenton J, Vilcoq JR et al (1993) Age as prognostic factor in premenopausal breast carcinoma. Lancet 341: 1039–1043

    Article  PubMed  Google Scholar 

  50. Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ, Silcocks PB (1993) Nm23 protein expres¬sion in ductal in situ and invasive human breast carcinoma. J Natl Cancer Inst 85: 727–731

    Article  PubMed  CAS  Google Scholar 

  51. Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ, Harris AL (1987) Epidermal-growth- factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1 (8547): 1398–1402

    PubMed  CAS  Google Scholar 

  52. Satariano WA, Ragland DR (1994) The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120: 104–110

    PubMed  CAS  Google Scholar 

  53. Schneider E, Horton JK, Yang CH, Nakagawa M, Cowen KH (1994) Multidrug resistance- associated protein gene overexpression and reduced drug sensitivity to topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 54: 152–158

    PubMed  CAS  Google Scholar 

  54. Scholl SM, Pallud C, Beuvon F, Hacene K, Stanley ER, Rohtschneider L et al (1994) Anti- colony-stimulating-factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 86: 120–126

    Article  PubMed  CAS  Google Scholar 

  55. Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V Et Al (1993) p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 85: 965–970

    Google Scholar 

  56. Silvestrini R, Daidone MG, Gasparini G (1985) Cell kinetics as a prognostic marker in node- negative breast cancer. Cancer 56: 1982–1987

    Article  PubMed  CAS  Google Scholar 

  57. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–182

    Article  PubMed  CAS  Google Scholar 

  58. Spandidos DA, Agnantis NJ (1984) Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Hervey ras oncogene. Anticancer Res 4: 269–272

    PubMed  CAS  Google Scholar 

  59. Steele GD, Winchester DP, Menck HR, Murphy GP (eds) (1993) National Cancer Data Base annual review of patient care, 1993. American Cancer Society, Atlanta

    Google Scholar 

  60. Stenman U, Heikkinen R (1991) Serum markers for breast cancer. Scand J Clin Lab Invest 206: 52–59

    Article  CAS  Google Scholar 

  61. Thor A, Benz C, Moore D, Goldman E, Edgerton S, Landry J et al (1991) Stress response protein (srp–27) determination in primary human breast carcinomas: clinical, histologic, and prognostic correlations. J Natl Cancer Inst 83: 170–178

    Article  PubMed  CAS  Google Scholar 

  62. Thorpe SM, Rose C (1986) Oestrogen and progesterone receptor determinations in breast cancer: technology and biology. Cancer Serv 5: 505–525

    CAS  Google Scholar 

  63. Tuccari G, Rizzo A, Giuffre G, Barresi G (1993) Immunohistochemical detection of DNA topoisomerase type II in primary breast carcinomas: correlation with clinico-pathological features. Virchows Arch [A] 423: 51–55

    Article  CAS  Google Scholar 

  64. Veronese SM, Gambacorta M, Gottardi O, Scanzi F, Ferrari M, Lampertico P et al (1993) Proliferation index as a prognostic marker in breast cancer. Cancer 71: 3926–3931

    Article  PubMed  CAS  Google Scholar 

  65. Watson PH, Safneck JR, Le K, Dubik D, Shiu RPC (1993) Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J Natl Cancer Inst 85: 902–907

    Article  PubMed  CAS  Google Scholar 

  66. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH et al (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast cancer. J Natl Cancer Inst 84: 1875–1887

    Article  PubMed  CAS  Google Scholar 

  67. Weikel W, Beck T, Mitze M, Knapstein PG (1991) Immunohistochemical evaluation of growth fractions in human breast cancers using monoclonal antibody Ki-67. Breast Cancer Res Treat 18: 149–154

    Article  PubMed  CAS  Google Scholar 

  68. Werner M, Faser C, Silverberg M (1993) Clinical utility and validation of emerging biochemical markers for mammary adenocarcinoma. Clin Chem 39: 2386–2396

    PubMed  CAS  Google Scholar 

  69. Yahan SR, Neuberg DS, DiefTenbach A, Yacoub L (1993) Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score. Cancer 71: 3552–3559

    Article  Google Scholar 

  70. Yates JW, Chalmer B, McKegney FP (1980) Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45: 2220–2224

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. B. Burke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. V. P. Hutter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. E. Henson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chirurgische Universitätsklinik Erlangen, Krankenhausstr. 12, 91054, Erlangen, Germany

    P. Hermanek (Vorstand der Abteilung für Klinische Pathologie i. R.) (Vorstand der Abteilung für Klinische Pathologie i. R.)

  2. Princess Margaret Hospital, Department of Radiation Oncology, University of Toronto, 500 Sherbourne Street, Toronto, Ontario, M4X 1K9, Canada

    Mary K. Gospodarowicz

  3. Early Detection Branch, Division of Cancer Prevention and Control, National Cancer Institute, EPN Building, Room 305 9000 Rockville Pike, Bethesda, MD, 20892, USA

    D. E. Henson

  4. University of Medicine and Dentistry, New Jersey Medical School, Newark, NJ, USA

    R. V. P. Hutter (Clinical Professor of Pathology) (Clinical Professor of Pathology)

  5. Department of Pathology, Saint Barnabas Medical Center, Old Short Hills Road, Livingston, NJ, 07039, USA

    R. V. P. Hutter (Clinical Professor of Pathology) (Clinical Professor of Pathology)

  6. Uniformed Services University of the Health Sciences, Bethesda, MD, USA

    L. H. Sobin (Professor of Pathology) (Professor of Pathology)

  7. Division of Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC, 20306, USA

    L. H. Sobin (Professor of Pathology) (Professor of Pathology)

Rights and permissions

Reprints and permissions

Copyright information

© 1995 International Union Against Cancer, Geneva

About this chapter

Cite this chapter

Burke, H.B., Hutter, R.V.P., Henson, D.E. (1995). Breast Carcinoma. In: Hermanek, P., Gospodarowicz, M.K., Henson, D.E., Hutter, R.V.P., Sobin, L.H. (eds) Prognostic Factors in Cancer. UICC International Union Against Cancer / Union Internationale Contre le Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79395-0_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79395-0_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-58688-3

  • Online ISBN: 978-3-642-79395-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation